Armaviscon 1% syringe 2 ml

Area of application – orthopedics, rheumatology, traumatology, surgery, sports medicine. Armaviscon is a joint synovial fluid protector. It is used against the background of degenerative changes of synovial cartilage surface to improve joint mobility, decrease pain syndrome, decrease inflammatory reactions and restore homeostasis in cartilage.
Properties and efficacy

Indications

• to increase joint flexibility and eliminate pain caused by degenerative-dystrophic or post-traumatic joint changes;
• for rehabilitation after arthroscopy;
• to treat patients with increased physical stress and who regularly load the affected joint.

.

Active ingredient

Sodium hyaluronate

Interaction

Armaviscon should not be administered at the same time as other intra-articular injections, due to lack of significant experience.

Directions for use

Intra-articular. The contents of one filled syringe, 2 ml (20 mg), should be injected into the knee joint once a week, for 5 injections using the standard technique described below. Usually a 1.5 inch 21G needle is used for the knee joint, for other joints it is recommended to use an appropriate size needle (17G to 22G) depending on the joint.

Special Instructions

Sodium hyaluronate is obtained by fermentation of the bacteria Streptococcus equi and is carefully purified. Nevertheless, the physician must consider the potential risk associated with the injection of any biological substances.

Contraindications

• high sensitivity to the components of the product
• infection or skin lesions in the area of injection
• acute synovitis;
• children under 18 years of age (due to lack of clinical data).

.

Side effects

There may be moderate pain, swelling, fever and redness in the injection area, increased exudate in the joint cavity.

Similarities

Ostenil, Fermatron, GOU-ON, Ostenil Plus, Fermatron Plus, Adant, Heimovis, Hyalripayer-10 Chondroreparant, Optinol, Hyalon Prosthesis